These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32117733)

  • 1. High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas.
    Fu W; Wang W; Li H; Jiao Y; Weng J; Huo R; Yan Z; Wang J; Xu H; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Oncol; 2020; 10():78. PubMed ID: 32117733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CyTOF Analysis Reveals a Distinct Immunosuppressive Microenvironment in IDH Mutant Anaplastic Gliomas.
    Fu W; Wang W; Li H; Jiao Y; Weng J; Huo R; Yan Z; Wang J; Xu H; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Oncol; 2020; 10():560211. PubMed ID: 33614475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of clinically relevant subsets CD39
    Zhang QW; Zhu MX; Liu WF; Rui WW; Chen Y; Ding XY; Jiang YS; Wu ZY; Liu BB
    Transl Oncol; 2024 Jun; 44():101954. PubMed ID: 38608405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
    Lussier DM; Woolf EC; Johnson JL; Brooks KS; Blattman JN; Scheck AC
    BMC Cancer; 2016 May; 16():310. PubMed ID: 27178315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
    Xu-Monette ZY; Xiao M; Au Q; Padmanabhan R; Xu B; Hoe N; Rodríguez-Perales S; Torres-Ruiz R; Manyam GC; Visco C; Miao Y; Tan X; Zhang H; Tzankov A; Wang J; Dybkær K; Tam W; You H; Bhagat G; Hsi ED; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; van Krieken JH; Winter JN; Westin JR; Pham LV; Medeiros LJ; Rassidakis GZ; Li Y; Freeman GJ; Young KH
    Cancer Immunol Res; 2019 Apr; 7(4):644-657. PubMed ID: 30745366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma.
    Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
    Brain Tumor Pathol; 2012 Jul; 29(3):140-7. PubMed ID: 22648019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased exhausted CD8
    Tan J; Chen S; Huang J; Chen Y; Yang L; Wang C; Zhong J; Lu Y; Wang L; Zhu K; Li Y
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e266-e274. PubMed ID: 29943497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors.
    Qiu R; Zhong Y; Li Q; Li Y; Fan H
    Front Cell Dev Biol; 2021; 9():693215. PubMed ID: 34211978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Profiling of Tumor-Infiltrating CD4
    Sasidharan Nair V; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Soofi ME; Ouararhni K; Alajez NM; Abu Nada M; Elkord E
    Vaccines (Basel); 2020 Feb; 8(1):. PubMed ID: 32041340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
    Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
    Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
    Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
    Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.